People behind Swiss Innovation
The Inno-Swiss platform is dedicated to boost
Swiss innovation and the people behind

  • anthony-aho-crm.jpg
    Anthony Aho, CEO and co-founder of PB&B (credits www.pbbtech.ch)

    2014 Venture Kick winner PB&B raises CHF 2 million

    Di. 03.05.2016, 14:00

    The Lausanne based MedTech startup, PB&B, focusing on making Aesthetics and Plastic Surgery procedures natural and minimally invasive, today announced that it has raised CHF 2 million from a strategic investor....Read more

    PB&B, winner of Venture Kick in 2014, has raised 2 million Swiss Francs. “It is an equity investment of a single strategic investor”, explained CEO and co-founder Anthony Aho.

    The funds will be used to fund on-going R&D testing and development, in the view of launching a first clinical study by Q2-2017. Since 2014, pre-clinical studies have been conducted in collaboration with scientists and doctors from EPFL and HUG (University Hospitals of Geneva).

    The company has positioned itself as a novel remodeling injection in the market of fillers and fat transfer procedures, through implementation of a market entry strategy directed towards anti-aging and facial rejuvenation of the mid-facial area. The “PB&B Technology” uses biodegradable microspheres that are loaded with lipids and later injected into the skin in a controlled manner to increase the volume of fat tissues. As a result, the process directs the patient's own tissues to naturally rejuvenate the face and diminish any wrinkles for a period of up to 20 months on average; longer than with any dermal filler.

    About PB&B
    PB&B was founded in 2013 in Ecublens, Lausanne by a group of bioengineers who are working together with Swiss academic institutes and doctors to develop their technology and products. Their passion for Aesthetics has enabled them to win a number of awards including Venture Kick, venture leaders, HUG Innovation Trophy 2014 and they have also been nominated in several others internationally.

  • buddy-team1.png
    The BuddyBroker team: Flurin Müller and Patrick Mollet

    XING buys Venture Kick startup BuddyBroker

    Di. 03.05.2016, 14:00

    XING has acquired the 2012 Venture Kick startup BuddyBroker and its product eqipia. eqipia is the leading intelligent and automated employee referral programme in Switzerland. The purchase price is set at CHF 3.2m. ...Read more

    An earn-out payment of up to CHF 4.8m may also take effect if the operative goals are reached. BuddyBroker AG has seven employees who will all continue working for the company. Both founders, Flurin Müller (30) and Patrick Mollet (39), will stay on board to drive the product's further development. Companies like Migros, Swisscom, SBB, Zühlke, BKW (Bernische Kraftwerke) and EMC have already begun using eqipia successfully.

    Employee referrals are on the rise in HR. In the USA, around 40 percent of all new hires can be attributed to referrals from employees. Employee referrals are already the most effective recruiting tool in the German-speaking world today. Most companies have implemented a bonus programme in order to make use of employee referrals. This, however, is a manual process that is inefficient and time-consuming for both HR and employees. 

    The “eqipia ReferralManager” digitalises and automates this complex process. It analyses employees' networks, which it can access via their XING profiles, and identifies suitable colleagues using a matching algorithm. These potential candidates can then be contacted automatically via the tool, significantly reducing the workload in HR. The employees concerned receive all the important information about the vacancy and can pass this on to their contacts. HR departments then receive transparent reports about the success of the recruiting tool. They also have the option of awarding a bonus for the successful referral of a contact. 

    Read full press release here.

  • Alberto-Hernando_SThAR-crm.jpg
    Alberto Hernando, CEO of SThAR

    Xorlab003-crm.jpg
    The team of xorlab: from left to right, CTO Matthias Ganz, CEO Antonio Barresi and COO Marco Nembrini.

    Helping marketing campaigns go viral and prevent attacks from cyber criminals: two promising startups kicked by CHF 130.000 each at the Venture Kick final

    Mi. 27.04.2016, 14:00

    Two great IT startups, SThAR from EPF Lausanne and xorlab from ETH Zurich, raised CHF 130.000 each by winning the third and last round of Venture Kick. Both startups develop groundbreaking software technologies to help advertising agencies and politicians design wildfire-spreading campaigns, and companies or governments defeat cybercriminal attacks as well as cyber espionage. ...Read more

    What if an algorithm could predict collective human behavior and send the right messages to the right people, at the right time and place? For sure, marketers would like to use it to design efficient and viral advertising or electoral campaigns. Hopefully for them, SThAR has got it all. The EPFL spin-off developed a software capable of identifying where and when to deliver a message most effectively and create buzz both on traditional (offline) and online media such as social media.

    SThAR: When the laws of physics apply to marketing
    SThAR develops predictive softwares based on an emergent science called “sociothermodynamics”. Their algorithms draw on large quantities of telecommunications data from telecommunication companies (i.e. mobility, connectivity) to generate a roadmap with the best places and the best times for executing coordinated marketing actions. SThAR’s predictive models are borrowed from physics, the field of CEO Alberto Hernando: “After my PhD in quantum mechanics and complex systems, I started to study social and economic processes behind electoral results or demographics using mathematical methods. I got fairly good results about describing and predicting population flows and opinion dynamics” he explains. SThAR’s system was successfully tested during local elections in Spain and is now on its way to the market, thanks to the money of Venture Kick: “Venture Kick is not just about the money, but about the support that we found from the excellent professionals to enhance the robustness of our business strategy and make a market entry a reality”. To help him boost his venture, Hernando was recently selected in the venture leaders in Technology team of 2016. He will present his Big Data technology to American investors in June.

    xorlab: Defeat sophisticated cyber-attacks beyond conventional and easy to break solutions
    Cyber-attacks can bring companies or even states to their knees. Take the attacks on the computers of the German Federal Chancellor and the US State Department last year, or the ones on the American bank HSBC early 2016, which led to the shutdown of its e-banking and mobile services. xorlab’s innovative software solution protects against so-called “client-side attacks” such as “spear phishing”, “watering hole” attacks or “drive-by” infections, which open up a pathway to an organization's IT infrastructure and are usually the first step in a targeted attack. The product, a hardware appliance, can be integrated in the customers’ network and goes beyond conventional computer security solutions. It allows the data coming from external emails (i.e. PDFs, Word or Excel documents) and websites to be scanned, in order to check whether they try to attack the computers of an organization. The victory at Venture Kick comes at the right time for Antonio Barresi, xorlab’s CEO: “We already have two pilot customers. Now, our objective is to deploy our product’s first beta version in a productive environment.” The help of Venture Kick was substantial for Barresi to achieve his goals: “The direct feedback received at the kickers camps were very instructive and the pressure, a real driver. We were forced to dare the next strategic steps and not only focus on the technology.” 

  • G-Therapeutics_VincentDelattre_allrights_1.png
    Vincent Delattre, co-Founder at G-Therapeutics

    G-Therapeutics raises EUR 36 million to develop novel neuro-stimulation therapy for spinal cord injury

    Di. 19.04.2016, 00:00

    The TOP 100 Swiss Startup 2015 G-Therapeutics has raised EUR 36 million to develop its novel neuro-stimulation therapy for people with spinal cord injuries. ...Read more

    G-Therapeutics will use the funds to bring a unique, new therapy for improved rehabilitation of spinal-cord injuries from the lab to patients. In particular, the Company is developing a unique, Implantable Neuro-stimulation System for electrical stimulation of specific areas of the spinal cord and will subsequently perform a multi-center clinical study to obtain regulatory approval.

    The Swiss-Dutch Company is building further upon the scientific achievements of Professor Grégoire Courtine, who occupies the International Paraplegic Foundation Chair in Spinal Cord Repair, and his colleagues at the Center for Neuro-prosthetics and Brain Mind Institute of  EPFL and at the University Hospital of Vaud. For over 15 years, Professor Courtine has been working on unravelling the mechanisms underlying an effective treatment for people with a spinal cord injury affecting the lower limbs. As one of the founders and Chief Scientific Officer of the Company, Professor Courtine comments: "I am delighted that after a decade of dedicated research and all the scientific accomplishments of my team, G-Therapeutics will enable the development of realistic therapeutic solutions for people with spinal cord injury."

    2014 the EPFL spin-off was part of the Swiss national startup team in Boston and New York and won 30'000 CHF from Venture Kick. Learn more about the startup in the video interview with co-founder Vincent Delattre:

  • Header_VL2016.png

    Two new Swiss startup teams selected to conquer the US market and its investors in June

    Do. 14.04.2016, 12:00

    As novelty in 2016, not only one, but two “Swiss startup teams” have been selected for the US journey as part of the international program venture leaders. Nine Venture Kick alumni are part of the teams. Don't miss them....Read more

    The venture leaders in Life Sciences and the venture leaders in Technology teams, composed of 10 high potential startups each, will fly to Boston and New York this summer for a “business boosting” week which will enable them to accelerate their development on the US market, meet top investors and experts. Selected after a highly competitive process, both teams offer an amazing display of startups to watch for future success.

    Over the past 15 years, the venture leaders program has been a cornerstone behind the success of numerous Swiss startups at a global scale such as STAFF FINDER, Europe’s Nr. 1 on-demand marketplace for temporary staffing, who announced the completion of a growth equity investment led by One Peak Partners and Goldman Sachs Private Capital early March. “The biggest learning with the venture leaders in Boston was without doubt the glance outside Swiss frontiers. The contacts and experience were a gold mine. We could also find an investor for STAFF FINDER while there“, explains CEO and founder Viktor Calabrò. 

    A once in a lifetime opportunity for world-class startups
    “venture leaders pursues its mission to play a key role in identifying and accelerating the development of some of the most promising Swiss startups at the international level”, explains Jordi Montserrat, Director of venturelab. “For the winning startups, to spend this intense week with top entrepreneurs who have global ambitions in thriving entrepreneurial and business ecosystems such as New York and Boston, is a once in a life time opportunity.” Whereas Switzerland is a fantastic place to launch and establish a startup, growth takes place at the international level: “Early exposure to the US market and its investors is a necessity for any startup with global potential.”

    A more targeted offer for the winning startups
    After 15 successful editions of venture leaders USA bringing 20 Swiss entrepreneurs to Boston and New York during 10 days, the program was split in two this year to better fit with the needs and expectations of the two ecosystems’ investors and to offer a more targeted option to the winning candidates. “Boston and New York are both world class innovation ecosystems, but have different strengths. For example,  Boston is extremely strong in domains such as biotechnology, medtech or energy, whereas New York offers great opportunities in fields such as mobile apps, fintech, media or Big Data”, explains Felix Moesner, Swiss Consul and CEO of swissnex Boston, venturelab’s longtime partner and co-organizer of the venture leaders trips in the US. New York and Boston now await the next ambassadors of Swiss innovation in the US. Stay tuned to follow their adventures: Hashtags: #vleaders, #vleadersBOS, #vleadersNYC.

    #vleadersBOS: the venture leaders in Life Sciences Boston 2016 at a glance

    Andrea Maesani, Intento (medtech), EPF Lausanne, Venture Kick (30'000) 2016
    A solution for the rehabilitation of severely paralyzed stroke patients, helping them to perform and recover upper limbs movements again.

    Martin Ostermaier, InterAx Biotech (biotech), PSI and ETH Zurich, Venture Kick (30'000) 2015
    InterAx Biotech helps pharmaceutical companies to develop new and better drugs. Their unique combination of computational methods and innovative biological products allows for fast and comprehensive characterization of potential new drugs. Costly clinical trials can then be performed with reduced risks.


    The team of InterAx Biotech

    Philipp Knechtle, Selmod (biotech), Uni Basel, Venture Kick (10'000) 2016
    Development of innovative small molecule therapies for the treatment of life-threatening invasive fungal infections, which represent around 2 million new cases every year worldwide.

    Sabrina Badir, pregnolia (medtech), ETH Zurich, Venture Kick (30'000) 2015
    A diagnostic tool that measures the cervical stiffness in pregnant women, allowing to reliably identify women at risk of preterm birth, thus solving the long-standing problem of preterm birth risk assessment and management in pregnancy.


    Sabrina Badir, CEO of Pregnolia

    Tomas de Wouters, PharmaBiome (biotech), ETH Zurich, Venture Kick (30'000) 2015
    Antibiotic resistances make intestinal infections (i.e. C. difficile infection) life-threatening. Fecal microbiota transplant, the transplant of feces from a healthy donor to the infected patient, is currently the only lifesaving but experimental therapy with success rates of over 90%. PharmaBiome develops a scalable, controllable and efficient alternative to the use of fecal material to make it the treatment of choice for intestinal infections.

    Check all venture leaders in Life Sciences profiles online
     
    #vleadersNYC: the venture leaders in Technology New York 2016


    Alberto Hernando, SthAR (software), EPF Lausanne, Venture Kick (30'000) 2016
    Algorithms that draw on large quantities of telecommunications data to identify where and when to deliver a message most effectively. The software product could be useful in both electoral and advertising campaigns.


    The founder of SThAR Alberto Hernando

    Daniel Meier, Aerotain (engineering), ETH Zurich, Venture Kick (30'000) 2016
    Fun and interactive flying solutions to boost the attention and coverage of brands and products. Applications range from advertisement and entertainment to live streams of events from the air. Check an example in video here

    Mathias Haussmann, Uepaa AG (web, mobile), ETH spin-off, Venture Kick (130'000) 2012
    Uepaa is a quickly growing «peer-to-peer»software company  (SaaS) based in Zurich that enables developers to integrate proximity features into their apps. Internationally awarded for its disruptive p2p safety app in 2013, the company launched its Software Development Kit (SDK called www.p2pkit.io) in October 2015. Uepaa has already seen tremendous uptake, with over 300+ clients from over 40 countries. Additionally Uepaa was recognized by 451 Research among others, as being a first-mover and leader in the proximity-based services space! Check out their video here


    Founders of Uepaa

    Michela Puddu, Haelixa (materials), ETH Zurich, Venture Kick (10'000) 2016
    Haelixa provides intelligent DNA-based tracing solutions allowing fluid/item tracking and parameter monitoring (temperature, light, pH, oxidants) to support the energy industry (underground exploration and monitoring), and ensure product authentication and quality control as well as liability management.

    Check all venture leaders in Technology profiles online

  • treatech-crm1.jpg
    Frédéric Juillard is the founder and CEO of TreaTech (cleantech)

    Rovenso008-crm1.jpg
    Thomas Estier and Lucian Cucu, co-founders of ROVENSO (robotics)

    Two innovative startups win the second stage of Venture Kick

    Di. 12.04.2016, 11:00

    The EPF Lausanne startups TreaTech and ROVENSO won the second stage of Venture Kick, with CHF 20‘000 each. Before they compete on the third and final stage of our program, where they might win another CHF 100’000, we give you an impression of the new rising stars....Read more

    The EPF Lausanne startup TreaTech develops a solution that will revolutionize the waste management of sewage sludge by turning it into fresh water, biogas, and natural fertilizers. This not only makes the sludge a new form of revenue instead of a cost to companies, but it will also reduce contamination effects. In the long-run, TreaTech aspires to provide water-related solutions and renewable energies worldwide. 

    “Aside from the financial support, Venture Kick is the perfect way for entrepreneurs to better understand their potential. Winning a Venture Kick round provides self-confidence, credibility, and a great support from experienced advisors. It is also a perfect driver to raise interest from potential partners or investors”, explains TreaTech's CEO Frédéric Juillard. 

    Listen to Frédéric Juillard's interview on RTS La Première (#neophiles program, in French) on 12.04.2016: "Phosphate - TreaTech".

    The mission of the EPF Lausanne spinoff ROVENSO is to design, manufacture and market agile robots that preserve human life from hazardous operations in nuclear decommissioning and emergency response.

    Watch ROVéo Mini, ROVENSO's robot: 

    ROVéo's unique four-wheel design allows it to climb over obstacles up to two-thirds its height. ROVENSO is working on a larger scale version of their robot (250kg) as well as on a portable Human-Machine Interface to operate dismantling robots.

    Early 2016, SOSV (Sean O’Sullivan Ventures) invested in the startup and the whole ROVENSO team flew to China joining the hardware accelerator HAX in Shenzhen to speed up their development.

    ROVENSO is currently producing a larger-scale model of ROVéo that can embed a heavy-duty robotic arm for use in nuclear dismantling but also in other hostile environments, where "everyday heroes" like firefighters and rescue workers risk their lives to help others (i.e. during and after natural and industrial disasters).

    "VentureKick is the most valuable program for early stage startups in Switzerland. Since the beginning, they are challenging every aspect of your business model and your go-to-market strategy forcing you to embrace a clear and global roadmap for your startup", explains ROVENSO co-founder and CEO Thomas Estier.

    In 2015, ROVENSO was selected among the venture leaders in Technology to attend a unique entrepreneurial and business development program in New York as well as Boston. You can watch ROVENSO's co-founder Lucian Cucu talk about his trip here.

  • vir2sense-crm.jpg
    The team of Vir2sense

    Atana-crm.jpg
    Atana Engineering

    Four new promising startups win the first stage of Venture Kick

    Mo. 11.04.2016, 11:00

    Four new early stage projects recently entered the Venture Kick program by winning its first stage: Vir2sense, ATANA Engineering, “Zero” and Sound-Proof. They win CHF 10’000 each. In the coming months, they will learn about execution in building a startup at the kickers camps. ...Read more

    Vir2sense: Virtual combustion and emission sensors
    The idea behind Vir2sense is to equip combustion engines ranging from automotive to ship propulsion with virtual combustion and emission sensors. These sensors simplify the engine calibration process and help to fulfill the increasingly stringent emission legislations, especially in real driving conditions.

    ATANA Engineering: A new high-tech self-service wardrobe system
    Smart Wardrobe Systems develops a new high-tech self-service wardrobe system, which can be used at event sites, such as conference centers, fairs or malls. The product increases operational efficiency of event organizers as well as users’ satisfaction and convenience.

    Zero”: An automated design to build pipeline based on a groundbreaking 3D printing technology
    The lean solution is an automated design to build pipelines based on a groundbreaking 3D printing technology that constructs lightweight buildings and bridges like Lego pieces. The next generation CAAD software that runs the 3D printer has artificial intelligence at the core of its kernel that compresses building data by factor 1’000, allowing the highest level of mass-customization and exchange of data with the least amount of programming.

    Sound-Proof: A fast, usable and secure 2FA mechanism
    Passwords are weak and get reused. Websites can use two-factor authentication (2FA) to prevent account breaches. Users don't like 2FA because it is cumbersome. Sound-Proof is a fast, usable and secure 2FA mechanism that companies want and users like.

  • Gamaya003-crm.jpg
    The EPFL spin-off and 2014 Venture Kick startup Gamaya traveled to Silicon Valley with the Swisscom Startup Challenge in 2015 and made its entry in the TOP100 Swiss Startups ranking, among other milestones.

    inositec-crm.jpg
    Inositec is a 2010 Venture Kick startup. Its CEO, Mattias Ivarsson, met US investors with the venture leaders in Life Science in Boston in 2014.

    Five Venture Kick startups shortlisted for the Vigier Award 2016

    Do. 31.03.2016, 11:00

    On May 19th the W.A. De Vigier Foundation will name five Swiss Startups to receive its award, each endowed with CHF 100‘000. According to Regula Buob, Managing Director of the foundation, the quality of the roughly 200 submitted projects was very high and the choice wasn’t easy. Now ten innovative startups from various industries have been chosen, among which five are Venture Kickers: Gamaya, Inositec, Nanolive, Pregnolia and UrbanAlps....Read more

    „The selection is a challenging and time consuming task! The board members work together with external scientific and economic experts and invest many hours every year, some of which are pro bono“, says Regula Buob. The projects are evaluated according to the following criteria: The entrepreneurial spirit of the CEO, the degree of innovation, the value for society as a whole, the technical and financial viability, market prospects and the potential for job creation.

    The Venture Kick nominees

    Gamaya from Ecublens (VD): Gamaya delivers large-scale analytics of farmland. Farmers are provided with actionable information about their land and crops, which can increase profit margins by at least 30% while raising the quality of produce and making farming more sustainable. More info

    Inositec from Zurich (ZH): Inositec is developing novel therapeutics from its proprietary platform of small molecules. The lead product is a novel treatment for a widespread colon infection and the second is an inhibitor of vascular calcifications. More info

    Nanolive from Ecublens (VD): Nanolive’s technology allows the exploration of living cells in 3D and without damaging them. The 3D Cell Explorer shows a comprehensive representation of the cells' activity in real time based on their physical properties. More info

    Pregnolia from Zurich (ZH): In the US and Europe less than half of the women at risk for preterm birth are detected. Pregnolia measures cervical stiffness and can reliably assess the risk of preterm birth, enabling early therapeutic intervention. More info

    UrbanAlps from Zurich (ZH): Today anybody can copy your house key. UrbanAlps brings the Stealth Key: an inexpensive mechanical key that is safe against 3D duplication. The solution is plain simple, a key which hides most of its mechanical security features internally – rendering the key unscannable. More info

    Check the Vigier Award's full ten nominee's list here
     

  • amaltherapeutics01-crm1.jpg
    Madiha Derouazi, CEO and founder of Amal Therapeutics

    Amal Therapeutics raises CHF 3 million in a Series A financing round led by Boehringer Ingelheim Venture Fund

    Mi. 30.03.2016, 14:00

    (30.03.2016) Amal Therapeutics (Amal) completes CHF 3 million (EUR 2.75 million) Series A financing round with Boehringer Ingelheim Venture Fund (BIVF) as cornerstone investors. VI Partners and High-Tech Gründerfonds also participated in the round which will help progress Amal’s cancer vaccines....Read more

    Amal Therapeutics is a Swiss biotech company developing and progressing therapeutic cancer vaccines. The company will use the funds to progress the preclinical development of its lead vaccine (ATP124) for colorectal cancer and to further develop its KISIMA technology platform for therapeutic tumor vaccination. This novel technology is able to generate potent long lasting anti-tumor immunity and avoid tumor immune escape.

    Dr. Frank Kalkbrenner from the Boehringer Ingelheim Venture Fund and Dr. Frank Hensel from the High-Tech Gruenderfonds will join the Board as Board Observers. Dr. Diego Braguglia from VI Partners will also become a member of Amal’s Supervisory Board.

    Dr. Madiha Derouazi, CEO and founder of Amal Therapeutics said: “This Series A investment recognizes the potential of the KISIMA technology platform and the value of our scientific assets. We are now in a position to rapidly progress our lead vaccine, ATP124, for colorectal cancer into the clinic and continue to develop our pipeline in other cancer indications. I look forward to working with the Board to make Amal Therapeutics a leading innovator in the field of immunotherapies”.

    Dr. Knut Elbers, Boehringer Ingelheim Venture Fund representative on Amal’s Board added: “Dr. Derouazi’s dedicated leadership and scientific expertise allowed us to assemble a group of outstanding scientists to show proof-of-principle in a series of pre-clinical tumor studies. We are confident that Amal’s KISIMA technology could revolutionize the peptide-based cancer vaccine field – bringing an exciting new technology to the patient”.

    Dr. Braguglia, VI Partners: “We believe that the KISIMA technology is superior to many other tumor vaccine technologies, both as a stand-alone treatment and in combination with other vaccines or immuno-oncology treatment modalities. I’m pleased to be joining the current seasoned investors and support the team of Amal in moving its technology into the clinic”.

    Amal’s vaccines combine a Cell Penetrating Peptide (CPP) with a multi-antigenic chimeric cargo with various CD8+ and CD4+ epitopes and a constitutive activator of dendritic cells, enabling them to simultaneously stimulate multi-epitopic cytotoxic T cell-mediated immunity, induce helper T (Th) cells and promote immunological memory.

    About Amal Therapeutics SA
    Amal Therapeutics SA is a privately held Swiss biotech company that was incorporated in 2012 as spin-off from the University of Geneva. Under the leadership of Dr. Madiha Derouazi, the company achieved a significant milestone by successfully developing KISIMA, a novel proprietary vaccine technology platform dedicated to oncology indications. Amal Therapeutics is a Venture Kick startup and a venture leader USA 2012.

  • irsweep-crm.png
    The team of IRSweep

    pregnolia-crm.png
    Sabrina Badir of Pregnolia

    Two Venture Kickers nominated for the Pionierpreis 2016

    Mi. 30.03.2016, 00:00

    The Pionierpreis will be attributed on April 12. Among the three finalists are two Venture Kick alumni, IRSweep und Pregnolia. ...Read more

    Will one of them be tomorrow’s prize holder and win the “almost CHF 100.000 prize”, such as our alumnus Nanolive in 2015? 

    Laser light makes substances in gases and liquids visible
    The ETH spin-off IRsweep develops unique spectroscopic sensors that efficiently examine the composition of gaseous and liquid substances. Compared to current methods, the technology enables a faster, more reliable and more versatile analysis of such substances. The innovation lies in the use of multi-colored and particularly precise lasers. The system is interesting for many applications in food, oil and pharmaceutical industries as well as for security solutions.

    In December 2015, IRsweep won the final of Venture Kick: "We have brought our first products on the market in 2015, the so-called "IRcell”. Thanks to the Venture Kick prize, we are now able to push the commercialization of our spectroscopy system forward", says Dr. Markus Geiser, co-founder of IRsweep.

    Reducing the risk of prenatal birth
    Pregnolia is developing a diagnostic tool that measures cervical stiffness in pregnant women. Monitoring cervical stiffness allows to reliably identify women at risk of preterm birth, thus solving the long standing problem of preterm birth risk assessment and management in pregnancy.

    The founder of Pregnolia, Sabrina Badir, will soon be in the Venture Kick final, after she won the second stage of our program in the light of candles in December 2015.

Angezeigt: 1 bis 10 von 270 1 2 3 4 5 6

Watch videos from success stories

TOP 100 Startups

Powered by startup.ch and Handelszeitung

60 venture kickers made it to the TOP 100 startups

Each year, startup.ch launches the TOP 100 STARTUP AWARD in cooperation with the Handelszeitung. From over 100,000 young companies, the 100 most innovative and promising Swiss startups are picked by top startup experts.

Check out the TOP 100

venture leaders

venture leaders program – ten intense days in USA or China

Swiss startups ready to take over the World.

The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.

More

venture kick

Kick your startup idea to success with venture kick

venture kick helps potential entrepreneurs by giving them the opportunity to win up to CHF 130,000. Moreover, startups can also use the know-how of experienced experts and entrepreneurs and be granted access to a national network of investors.

Apply

venturelab workshops

Powered by industry professionals

Learn from entrepreneurs and industry leaders

In the last 10 years venturelab alumni have raised several 100 millions from investors and built successful businesses. Now they are ready to share with the next generation of talented hightech startups.

Learn more about the program

Directory of active investors

Powered by startup.ch

The investors in early stage Swiss startups

In the last 5 years the venture kick startups raised more than 365 millions. Following all these transactions we compiled and update the list of active startup investors in different fields and stages.

Filter your potential investors

Institut für Jungunternehmen

The first address for Startups in Switzerland

More than 50.000 startups were accompanied by the IFJ. A little more then 25 years ago, we have made it our mission to guide these entrepreneurs on their way to successful businesses. So they can develop their role as a part of the Swiss economy.

More

Connecting the dots between Switzlerand and the world

Gioia Vichis Deutscher is the director of swissnex Brazil. After spending four years as the Haed of Startup and Innovation Services for swissnex San Francisco, Gioia Deutscher is now taking the lead in opening a new swissnex office in Brazil.

More on Swissnex Brazil

Suzanne Hraba-Renevey is the director of swissnex Singapore. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex Singapore

Pascal Marmier is the director of swissnex China. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex China

Felix Moesner is the director of swissnex Boston. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex Boston

Chistian Simm is the director of swissnex San Francisco. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex San Francisco

Balz Strasser is the director of swissnex India. Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoree. Ut wisi enim ad minim veniam, quis nostrud exerci tation.

More on Swissnex India

  • 60 venture kickers made it to the TOP 100 startups

    Each year, startup.ch launches the TOP 100 STARTUP AWARD in cooperation with the Handelszeitung. From over 100,000 young companies, the 100 most innovative and promising Swiss startups are picked by top startup experts.

    Check out the TOP 100
  • Kick your startup idea to success with venture kick

    venture kick helps potential entrepreneurs by giving them the opportunity to win up to CHF 130,000. Moreover, startups can use the know-how of experienced experts and entrepreneurs and be granted access to a network of investors.

    More
  • Swiss startups ready to take over the World.

    The venture leaders have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.

    More
  • The first address for Startups in Switzerland

    More than 50.000 startups were accompanied by the IFJ. A little more then 25 years ago, we have made it our mission to guide these entrepreneurs on their way to successful businesses. So they can develop their role as a part of the Swiss economy.

    More